Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats
- 28 February 2015
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 141 (10), 1767-1778
- https://doi.org/10.1007/s00432-015-1943-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Notch inhibition promotes fetal liver stem/progenitor cells differentiation into hepatocytes via the inhibition of HNF-1βCell and tissue research, 2014
- Comparison of serum exosome isolation methods for microRNA profilingClinical Biochemistry, 2014
- MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3BMC Cancer, 2013
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathwaysCancer Letters, 2013
- MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?Hepatology, 2012
- Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytesDevelopment, Growth & Differentiation, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- The cancer stem cell: premises, promises and challengesNature Medicine, 2011
- MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinomaJournal of Hepatology, 2010
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999